350 Participants Needed

Nurse-Led Telemonitoring for Chronic Conditions

Recruiting at 3 trial locations
ES
TA
DN
Overseen ByDenise Ng, MHI
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

In Canada, 3 out of 4 Canadians aged 65 and older have at least one chronic condition, while 1 in 4 seniors reported having three or more. Caring for complex patients who usually have multiple chronic conditions (MCC) is one of the biggest challenges facing our healthcare system. For patients, the lack of coordination and continuity of care as they transfer between healthcare settings and healthcare providers (HCPs) often results in a higher risk of readmission, suboptimal and fragmented care plans, delays in required medical intervention, inadequate self-care, and confusion on whom they should contact when they have questions. For the patient's care team, they often have no indication how patients are doing between clinic visits unless the patient can provide a log of their home measurements (e.g., blood pressure). Therefore, they are unable to detect and intervene if their patient's health is worsening between visits.In order to address this increasing need to bridge the current gap in clinical management and self-care of complex patients during their transition from healthcare settings to home care, our team aims to design, implement and evaluate the SMaRT (Safe, Managed, and Responsive Transitions) Clinic, a nurse-led integrated care model facilitated by telemonitoring (TM). Specifically, the SMaRT Clinics aim to meaningfully introduce a nurse (or nurse practitioner) role to improve clinical coordination across patient care teams and reinforce proper self-care education through the use of telemonitoring. This project will be conducted in two phases across four years; Phase I: Design and Development, and Phase II: Implementation and Effectiveness Evaluation. Phase II research activities include enrolling 350 patients with complex chronic conditions in the SMaRT clinics across four study sites. The implementation and effectiveness of the SMaRT clinics will be evaluated through a mix of semi-structured interviews, ethnographic observation, patient questionnaires, and analyses of health utilization outcomes using propensity-matched controls from the ICES provincial database.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, as the trial focuses on telemonitoring for chronic conditions.

Is nurse-led telemonitoring safe for managing chronic conditions?

Nurse-led telemonitoring for chronic conditions, like asthma, has been shown to be feasible and satisfying for patients, with high compliance and low dropout rates, indicating it is generally safe for use in humans.12345

How does the Nurse-Led Telemonitoring treatment differ from other treatments for chronic conditions?

Nurse-Led Telemonitoring is unique because it allows patients to record their vital signs at home and send this information to nurses who can quickly respond to any health issues, potentially preventing hospital visits. This approach is different from traditional treatments as it emphasizes remote monitoring and timely nurse intervention, which can improve patient outcomes and is particularly beneficial for older adults with long-term conditions.46789

What data supports the effectiveness of the treatment Nurse-Led Telemonitoring for Chronic Conditions?

Research shows that nurse-led telemonitoring can improve outcomes for patients with chronic conditions. For example, a study on diabetes patients found that those using home telemonitoring had a lower death rate compared to those who did not use it. Additionally, patients with asthma reported high satisfaction and reliable results with nurse-led telemonitoring, indicating its feasibility and effectiveness.3481011

Who Is on the Research Team?

ES

Emily Seto, PhD

Principal Investigator

University of Toronto

Are You a Good Fit for This Trial?

The SMaRT Study is for adults over 18 who have recently been discharged from certain hospitals in Canada and have at least one chronic condition like heart failure, COPD, high blood pressure, diabetes, or depression. Participants need to be able to use the telemonitoring app and devices (like a weight scale) and speak English or have someone who can communicate for them.

Inclusion Criteria

Discharged from hospital or seen within 48 hours of discharge at Health Sciences North (HSN), William Osler Health Systems (WOHS), Women's College Hospital (WCH), and Markham Stouffville Hospital (MSH)
I have a chronic condition like heart failure or diabetes that could improve with telemonitoring.
Able to comply with use of the telemonitoring application and applicable peripheral devices (e.g., able to stand on the weight scale, able to answer symptom questions, etc.)
See 1 more

Exclusion Criteria

Patients who are discharged from hospital with the intent to be admitted to a long-term care facility will be excluded

Timeline for a Trial Participant

Design and Development

Design and development of the SMaRT Clinic model and telemonitoring system

2 years

Implementation and Effectiveness Evaluation

Implementation of the SMaRT Clinics and evaluation of their effectiveness through various research activities

2 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Telemonitoring
Trial Overview This study tests the SMaRT Clinic model which uses nurse-led care coordinated through telemonitoring to manage patients with multiple chronic conditions after they leave the hospital. It aims to improve self-care education and clinical coordination across patient care teams.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemonitoring (Medly MCC)Experimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+

Markham Stouffville Hospital

Collaborator

Trials
4
Recruited
2,500+

Health Sciences North

Collaborator

Trials
6
Recruited
1,100+

William Osler Health System

Collaborator

Trials
11
Recruited
36,100+

Women's College Hospital

Collaborator

Trials
108
Recruited
43,700+

Published Research Related to This Trial

In a randomized clinical trial involving 316 elderly heart failure patients, supplementing nurse case management with Internet-connected telemonitoring did not significantly reduce hospitalizations, emergency department visits, or mortality compared to case management alone.
Despite the lack of difference in the primary outcomes, participants in the telemonitoring group had 42% fewer inpatient days during the intervention compared to the previous year, highlighting the potential benefits of case management in managing heart failure.
Telemonitoring with case management for seniors with heart failure.Wade, MJ., Desai, AS., Spettell, CM., et al.[2022]
A home monitoring and care coordination program for veterans with diabetes significantly reduced all-cause mortality over four years, with 19% deaths in the intervention group compared to 26% in the control group.
The intervention group experienced longer survival times (mean of 1348 days) and a hazard ratio of 0.7 indicates a 30% reduction in the risk of death, suggesting that daily telemonitoring by care coordinators is effective in managing diabetes and improving patient outcomes.
Mortality risk for diabetes patients in a care coordination, home-telehealth programme.Chumbler, NR., Chuang, HC., Wu, SS., et al.[2009]
A nurse-led telemonitoring program for asthma patients, involving 55 participants over 12 months, demonstrated feasibility and reliability, with high patient satisfaction and a low dropout rate.
Despite some technical issues, most patients (at least 75%) provided valid peak expiratory flow (PEF) tests, indicating good compliance, although the average number of tests recorded was slightly below the required amount.
Process evaluation of a nurse-led telemonitoring programme for patients with asthma.Willems, DC., Joore, MA., Hendriks, JJ., et al.[2007]

Citations

Telemonitoring with case management for seniors with heart failure. [2022]
Mortality risk for diabetes patients in a care coordination, home-telehealth programme. [2009]
Process evaluation of a nurse-led telemonitoring programme for patients with asthma. [2007]
Nursing interventions in a telemonitoring program. [2021]
Telehomecare communication and self-care in chronic conditions: moving toward a shared understanding. [2022]
Benefits and Challenges of Remote Patient Monitoring as Perceived by Health Care Practitioners: A Systematic Review. [2023]
Home telehealth: facilitators, barriers, and impact of nurse support among high-risk dialysis patients. [2019]
Use of telemonitoring in patient self-management of chronic disease: a qualitative meta-synthesis. [2023]
Benefits of telemonitoring in the care of patients with heart failure. [2016]
The role of telemonitoring in caring for older people with long-term conditions. [2016]
11.United Statespubmed.ncbi.nlm.nih.gov
Telephone Support and Telemonitoring for Low-Income Older Adults. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceĀ·Privacy PolicyĀ·CookiesĀ·Security